ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
Subscribe To Our Newsletter & Stay Updated